Certara to Participate in Piper Sandler 33rd Annual Virtual Healthcare Conference
03 nov. 2021 08h00 HE
|
Certara
PRINCETON, N.J., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that William F. Feehery, Chief Executive Officer, and Andrew...
Pinnacle 21 Awarded FDA Contract for 5 Years for Software and Services
28 oct. 2021 08h00 HE
|
Certara
PRINCETON, N.J., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that the U.S. Food and Drug Administration (FDA) has awarded a...
Certara’s Simcyp™ COVID-19 Vaccine Model Wins R&D 100 Award
25 oct. 2021 16h30 HE
|
Certara
PRINCETON, N.J., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that its Simcyp COVID-19 Vaccine Model has won an R&D 100...
Certara to Report Third Quarter 2021 Financial Results on November 9th, 2021
19 oct. 2021 08h00 HE
|
Certara
PRINCETON, N.J., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of...
Certara 推出全新 Synchrogenix™ Writer 软件,加速监管审批流程
12 oct. 2021 23h40 HE
|
Certara USA, Inc.
新泽西州普林斯顿, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Certara 为全球生物模拟领域的领军企业,今日宣布推出一款全新的监管 SaaS 产品——Synchrogenix™ Writer。该产品可加快患者叙述的撰写和审查速度。患者叙述描述了不良事件或药物不良反应,对于整个临床阶段的每个治疗领域的临床研究报告都至关重要。 ...
Certara Appoints Patrick F. Smith to President of Integrated Drug Development
12 oct. 2021 08h00 HE
|
Certara
PRINCETON, N.J., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the appointment of Patrick F. Smith, Pharm.D. as president of...
Certara 完成对Pinnacle 21 的收购
11 oct. 2021 22h12 HE
|
Certara USA, Inc.
新泽西州普林斯顿, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Certara, Inc.(纳斯达克代码:CERT)为全球生物模拟领域的领军企业,今日宣布完成此前公布的 Pinnacle 21 收购交易,Pinnacle 21 为面向临床数据拟合、监管合规和审批准备的 SaaS 解决方案领先提供商。该交易完成后,Pinnacle 21 的股权持有人获得了约 2.5...
Certara Appoints Drayton T. Virkler as Chief Commercial Officer
05 oct. 2021 08h00 HE
|
Certara
PRINCETON, N.J., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the appointment of Drayton T. Virkler to the newly created position...
Certara Completes Acquisition of Pinnacle 21
04 oct. 2021 08h00 HE
|
Certara
PRINCETON, N.J., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the completion of the previously announced transaction to acquire...
Certara Launches New Synchrogenix™ Writer Software to Accelerate the Regulatory Submission Process
30 sept. 2021 16h30 HE
|
Certara
PRINCETON, N.J., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Certara, a global leader in biosimulation, today announced the launch of Synchrogenix™ Writer, a new regulatory SaaS product that expedites the...